Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Diabetes
MedTech
Abbott spinal cord stimulator nets FDA approval in diabetes pain
The company's Proclaim XR received a new approval from the FDA covering peripheral neuropathy caused by diabetes.
Conor Hale
Jan 26, 2023 11:21am
Tidepool lands long-awaited FDA nod for diabetes management app
Jan 25, 2023 10:33am
JPM23: Dexcom preps for the 'chaos' of the G7 global rollout
Jan 10, 2023 5:47pm
Embecta beats its own estimates in first 6 months of BD spinout
Dec 22, 2022 11:07am
2023 forecast: Will tech makers finally close the diabetes loop?
Dec 21, 2022 8:30am
Tandem offers $216M for insulin patch pump maker AMF Medical
Dec 13, 2022 10:50am